ID: ALA5202331

Max Phase: Preclinical

Molecular Formula: C17H17N5O2

Molecular Weight: 323.36

Associated Items:

Representations

Canonical SMILES:  CC(C)CCOc1ccc(-c2ncc3c(=O)[nH][nH]c3n2)cc1C#N

Standard InChI:  InChI=1S/C17H17N5O2/c1-10(2)5-6-24-14-4-3-11(7-12(14)8-18)15-19-9-13-16(20-15)21-22-17(13)23/h3-4,7,9-10H,5-6H2,1-2H3,(H2,19,20,21,22,23)

Standard InChI Key:  QULVRWGNRWFLOG-UHFFFAOYSA-N

Associated Targets(Human)

Xanthine dehydrogenase 1038 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 323.36Molecular Weight (Monoisotopic): 323.1382AlogP: 2.61#Rotatable Bonds: 5
Polar Surface Area: 107.45Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.51CX Basic pKa: 3.71CX LogP: 3.72CX LogD: 3.72
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.75Np Likeness Score: -1.12

References

1. Zhao J, Mao Q, Lin F, Zhang B, Sun M, Zhang T, Wang S..  (2022)  Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.,  229  [PMID:34992040] [10.1016/j.ejmech.2021.114086]

Source